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CASE REPORT
Vulvar intraepithelial neoplasia grade 3 
associated with Behçet’s disease
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Abstract 
Background: Little information is available regarding the association between vulvar intraepithelial neoplasia grade 
3 (VIN3) and Behçet’s disease (BD). We report here concomitant VIN3 and genital ulcers in a patient with BD.
Case: A 44-year-old Caucasian woman with a history of BD, which had been evolving for 6 years, presented with 
ulcerated and papillomatous lesions on the vulva. Biopsies revealed a multifocal VIN3 positive for high-risk human 
papillomavirus (HPV) 33. Multiple biopsies were performed to exclude invasive cancer and VIN3 was treated with laser 
vaporization.
Conclusion: We report clinical and anatomopathological features of a rare case of multifocal, high-risk, HPV-related 
VIN3. We also discuss the possible pathogenesis in the context of BD, featuring chronic ulceration and intrinsic or 
treatment-induced immunosuppression.
Keywords: Behçet’s disease, Genital ulceration, Human papillomavirus, Vulvar intraepithelial neoplasia
© 2016 Germann et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Behçet’s disease (BD) is a rare multisystemic and chronic 
autoinflammatory disease of unknown origin. Recur-
rent oral and genital aphthous lesions are nearly always 
present. Ocular inflammation, and neurological and vas-
cular manifestations are among the most severe compli-
cations of BD. Genital ulcerations are usually painful and 
develop around the anus, vulva, or scrotum, and may be 
at the origin of scar formation. Coexistence of BD and 
malignant tumors is rare [1], but association with genital 
neoplasms has been described in previous reports [2]. To 
the best of our knowledge, the association between BD 
and vulvar intraepithelial neoplasia grade 3 (VIN3) has 
not yet been described in the literature. We report here 
a woman who was affected by BD, presenting with vulvar 
ulcers coexisting with multifocal VIN3.
Case presentation
A 44-year-old Caucasian woman, who had a 6-year his-
tory of BD, presented with two different types of vulvar 
lesions, papillomatous and ulcerated lesions. Her medical 
gynecological history was compatible with persistence 
of long-term genital high-risk human papillomavirus 
(HPV), including excision of a previous large loop of the 
transformation zone, followed by a hysterectomy because 
of recurrent cervical intraepithelial neoplasia grade 3, 
10 years ago.
During the 6-year period, she had typical manifesta-
tions of BD, such as recurrent panuveitis, vitreous body 
hemorrhage, occlusive vasculitis, and oral aphthous 
lesions. Laboratory genetic analyses by PCR were nega-
tive for human leukocyte antigen (HLA)-B27 and posi-
tive for HLA-B51 (PCR-SSO typing using Luminex™, 
Luminex®, Austin, USA).
The patient received various immunosuppressive ther-
apies with prednisone in association with either metho-
trexate or cyclosporine and infliximab since the initial 
diagnosis in 2008 (Fig. 1). In 2012, treatment with inter-
feron alpha-2a was introduced and stopped in April 2013 
after complete clinical remission of the disease. One year 
later, she had recurrence, and colchicine was introduced.
Open Access
BMC Research Notes
*Correspondence:  daphne.germann@gmail.com 
†Daphné Germann and Rosa Catarino contributed equally to this work
1 Department of Gynecology and Obstetrics, Geneva University Hospitals, 
Geneva, Switzerland
Full list of author information is available at the end of the article
Page 2 of 4Germann et al. BMC Res Notes  (2016) 9:172 
Clinical assessment revealed a highly remodeled vulva 
with scar formation following recurrent BD (Fig.  2). At 
the right side, on the labia majora, we observed a slightly 
indurated and ulcerated nodule, suggestive of a malig-
nant lesion. We also noticed multiple white prominent 
areas on the labia minora and in the clitoridian region, 
compatible with a high-grade vulvar neoplasia. Anoscopy 
under colposcopic vision was normal.
Under general anesthesia, multiple biopsies were per-
formed to exclude an underlying invasive pathology, and 
the dysplastic lesions were treated by laser vaporization. 
A partial right vulvectomy of the labia majora contain-
ing an indurated nodule was removed in toto with a 
margin. Anatomopathological analysis showed an ulcer-
ated Malpighian mucosa. Multifocal biopsies of the labia 
minora and periclitoridian region confirmed the diagno-
sis of VIN3 with diffuse and strong p16 immunostaining 
(Fig.  3). Fresh material from biopsy specimens (VIN3 
areas) was analyzed for detection of HPV by a semi-
quantitative real-time PCR assay (Anyplex™ II HPV 28, 
Seegene®, Seoul, Korea) that detects 19 high-risk types 
and nine low-risk types. The HPV 33 genotype was 
identified.
The whole intervention was anamnestically well toler-
ated by the patient.
Discussion
Although BD has been described as an autoimmune and 
auto-inflammatory disorder, its etiology still remains 
unclear [3]. Studies have suggested that BD may be trig-
gered by viral or bacterial antigens. These antigens cause 
upregulation of interleukins, TNF-α, and interferon-β, 
leading to activation of neutrophils, which is at the origin 
of tissue damage. This process is encountered in patients 
who have a background of genetic susceptibility, such as 
in the current case, where HLA-B51 was positive. Stud-
ies have demonstrated HLA-B51 positivity in more than 
60 % of BD patients [4]. This gene is considered as a part 
of the major histocompatibility complex region of chro-
mosome 6 and is regarded as the primary association 
with BD within the major histocompatibility complex 
region [5, 6].
The usual type of VIN is related to high-risk HPV infec-
tion and is considered to be the precursor of high-risk, 
HPV-related, vulvar squamous cell carcinoma. These 
tumors show multifocality, and occur in younger women, 
especially if immunocompromised [7]. Pathogenesis of 
VIN3 in BD patients has not been clearly reported in 
the literature, but we assume that chronic vulvar inflam-
mation and ulceration may facilitate access of HPV into 
the basal layer of cells. As infected basal cells mature to 
the surface, viral replication and viral particle formation 
and release occurs, spreading the infection into adjacent 
tissues.
The autoimmune nature of BD and/or immunosup-
pressive treatment may be considered as a promoter of 
HPV persistence and evolution toward VIN3, and poten-
tially to cancer. BD-induced immunosuppression might 
lead to an inability to control the expression of HPV. 
Production of the HPV oncoproteins E6 and E7 leads to 
development of precancer and cancer in chronic high-
risk HPV infection. In our case, VIN3 was positive for the 
high-risk HPV 33 genotype and immunostaining showed 
clear overexpression of the protein p16INK4a. This over-
expression, which is present in almost all cervical inva-
sive cancer and precancer, has been shown to be directly 
Fig. 1 Timeline with main clinical events and patient’s treatment for Behçet’s disease since diagnosis. Mtx methotrexate
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linked to the transforming activity of E7 oncoprotein 
produced by HPV [8].
No data are available regarding the prevalence of HPV 
in BD and the risk of developing HPV-related, high-
grade, intraepithelial neoplasia in the anogenital area. 
Our patient had multiple genital scars that had formed 
in an indurated tender area, which can potentially be 
invasive cancer. Distinction between scars from BD and 
vulvar cancer may be a challenge in these patients. Our 
report should alert clinicians about the possibility of 
high-grade intraepithelial neoplasia in the anogenital 
area and the possibility of cancer occurring simultane-
ously with vulvar ulcers. Recognition of this condition 
is important both clinically and pathologically because 
small foci of VIN3 may be overlooked when evaluating 
vulvar lesions associated with BD. Therefore we suggest 
an accurate clinical gynecological exam with a biopsy 
for any suspicious area in women who are suffering from 
BD. Treatment is indicated for VIN3 and after resolu-
tion these women should probably be considered as at 
risk of recurrent VIN and vulvar cancer throughout their 
lifetimes.
Fig. 2 Vulvar clinical examination. Indurated, ulcerated nodule, 
observed as a benign lesion on biopsy (white arrow). White, multifo-
cal, pearly, heightened lesions in the periclitoridian and labia regions 
can be seen. Multiple biopsies confirmed multifocal VIN3 disease 
(black arrows)
Fig. 3 Microscopic findings of vulvar intraepithelial neoplasia grade 3 (VIN3), usual-type VIN. Left panel shows usual-type VIN 3, basaloid type, 
composed of a homogeneous population of abnormal parabasal cells. Hyperchromasia, anisonucleosis, and abnormal mitotic figures in almost the 
whole thickness of the epidermis can be seen (hematoxylin and eosin, 20×). Right panel shows diffuse and strong p16 positivity (p16, 10×)
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Conclusions
We report the first known case of high-risk HPV-related 
VIN3 occurring in association with BD. This case under-
lines BD as a chronic inflammatory disease of the ano-
genital area, predisposing to high-grade intraepithelial 
neoplasia. Prospective studies are needed to evaluate 
the prevalence of HPV in women with BD and the risk 
of acquiring anogenital intraepithelial neoplasia. We also 
recommend careful long-term follow-up of these patients 
with HPV testing, and biopsy for prompt diagnosis and 
proper treatment.
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